Dosages & Reactions

Interactions:

Amoxycillin
Adverse Effect: loss of Gentamicin efficacy
Clinical Management: Monitor patients for Gentamicin effectiveness.
Amoxycillin + Bromhexine Comb.
Adverse Effect: Loss of aminoglycoside efficacy
Clinical Management: Monitor patients for aminoglycoside effectiveness.
Amoxycillin + Carbocisteine Comb.
Adverse Effect: Loss of aminoglycoside efficacy
Clinical Management: Monitor patients for aminoglycoside effectiveness.
Amoxycillin + Clavulanic Acid Comb.
Adverse Effect: Loss of aminoglycoside efficacy
Clinical Management: Monitor patients for aminoglycoside effectiveness.
Amoxycillin + Cloxacillin Comb.
Adverse Effect: Loss of aminoglycoside efficacy
Clinical Management: Monitor patients for aminoglycoside effectiveness.
Ampicillin
Adverse Effect: loss of Gentamicin efficacy
Clinical Management: Monitor patients for Gentamicin effectiveness.
Atracurium
Adverse Effect: enhanced and/or prolonged neuromuscular blockade which may lead to respiratory depression and paralysis
Clinical Management: Avoid concomitant use of Gentamicin and Atracurium if possible. Concurrent use of Gentamicin and Atracurium requires close monitoring of the patients clinical condition, especially respiratory and oxygenation status.
Bacampicillin
Adverse Effect: Loss of Gentamicin efficacy
Clinical Management: Monitor patients for Gentamicin effectiveness.
Benzathine Penicillin
Adverse Effect: Loss of Gentamicin efficacy
Clinical Management: Monitor patients for Gentamicin effectiveness.
Benzyl Penicillin
Adverse Effect: loss of Gentamicin efficacy
Clinical Management: Monitor patients for Gentamicin effectiveness.
Bumetanide
Adverse Effect: ototoxicity
Clinical Management: Consider periodic auditory testing for patients with renal dysfunction, or for patients on high doses of either drug.
Capreomycin
Adverse Effect: gentamicin toxicity (ototoxicity, nephrotoxicity)
Clinical Management: If concomitant administration is necessary, respiratory function, renal function and auditory function should be monitored closely.
Carbenicillin
Adverse Effect: Loss of Gentamicin efficacy
Clinical Management: Monitor patients for Gentamicin effectiveness.
Carboplatin
Adverse Effect: ototoxicity
Clinical Management: If clinically acceptable, an alternate antibiotic (a non-aminoglycoside) may be preferred.
Cefaclor
Adverse Effect: an increased risk of nephrotoxicity
Clinical Management: Coadministration of Gentamicin with Cefaclor could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cefadroxil
Adverse Effect: an increased risk of nephrotoxicity
Clinical Management: Coadministration of Gentamicin with Cefadroxil could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cefazolin
Adverse Effect: an increased risk of nephrotoxicity
Clinical Management: Coadministration of Gentamicin with Cefazolin could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cefixime
Adverse Effect: an increased risk of nephrotoxicity
Clinical Management: Coadministration of Gentamicin with Cefixime could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cefoperazone
Adverse Effect: an increased risk of nephrotoxicity
Clinical Management: Coadministration of Gentamicin with Cefoperazone could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cefotaxime
Adverse Effect: an increased risk of nephrotoxicity
Clinical Management: Coadministration of Gentamicin with Cefotaxime could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cefpirome
Adverse Effect: an increased risk of nephrotoxicity
Clinical Management: Coadministration of Gentamicin with Cefpirome could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cefpodoxime
Adverse Effect: an increased risk of nephrotoxicity
Clinical Management: Coadministration of Gentamicin with Cefpodoxime could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Ceftazidime
Adverse Effect: an increased risk of nephrotoxicity
Clinical Management: Coadministration of Gentamicin with Ceftazidime could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Ceftizoxime
Adverse Effect: an increased risk of nephrotoxicity
Clinical Management: Coadministration of Gentamicin with Ceftizoxime could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Ceftriaxone
Adverse Effect: an increased risk of nephrotoxicity
Clinical Management: Coadministration of Gentamicin with Ceftriaxone could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cefuroxime
Adverse Effect: an increased risk of nephrotoxicity
Clinical Management: Coadministration of Gentamicin with Cefuroxime could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cephalexin
Adverse Effect: an increased risk of nephrotoxicity
Clinical Management: Coadministration of Gentamicin with Cephalexin could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cephaloridine
Adverse Effect: an increased risk of nephrotoxicity
Clinical Management: Coadministration of Gentamicin with Cephaloridine could produce additive nephrotoxic effects. Use of these agents should be avoided in patients with prior renal insufficiency. If coadministration of these two antibiotic classes is necessary, patients should be monitored for evidence of nephrotoxicity.
Cloxacillin
Adverse Effect: Loss of Gentamicin efficacy
Clinical Management: Monitor patients for Gentamicin effectiveness.
Cyclosporin
Adverse Effect: Nephrotoxicity
Clinical Management: Monitor for signs and symptoms of nephrotoxicity and administer the drug with caution.
Frusemide
Adverse Effect: ototoxicity and/or nephrotoxicity
Clinical Management: Consider periodic auditory testing for patients on high doses of either drug. Also monitor renal function.
Indomethacin
Adverse Effect: Gentamicin toxicity (renal dysfunction, ototoxicity)
Clinical Management: Monitor aminoglycoside levels closely for one to two days as well as renal function after starting or discontinuing indomethacin.
Mg. salts
Adverse Effect: Neuromuscular weakness
Clinical Management: Monitor patients for respiratory dysfunction and apnea. If neuromuscular blockade occurs, discontinue Gentamicin and change antibiotic therapy. Patients receiving large cumulative dose of Gentamicin should have serum calcium, magnesium, potassium, and creatinine monitored.
Pancuronium
Adverse Effect: enhanced and/or prolonged neuromuscular blockade which may lead to respiratory depression and paralysis
Clinical Management: Avoid concomitant use of Gentamicin and Pancuronium if possible. Concurrent use of Gentamicin and Pancuronium requires close monitoring of the patients clinical condition, especially respiratory and oxygenation status.
Penicillin V ( Phenoxymethyl )
Adverse Effect: loss of Gentamicin efficacy
Clinical Management: Monitor patients for Gentamicin effectiveness.
Pipecuronium
Adverse Effect: enhanced and/or prolonged neuromuscular blockade which may lead to respiratory depression and paralysis
Clinical Management: Avoid concomitant use of Gentamicin and Pipecuronium if possible. Concurrent use of Gentamicin and Pipecuronium requires close monitoring of the patients clinical condition, especially respiratory and oxygenation status.
Piperacillin
Adverse Effect: Loss of Gentamicin efficacy
Clinical Management: Monitor patients for Gentamicin effectiveness.
Procaine Penicillin
Adverse Effect: Loss of Gentamicin efficacy
Clinical Management: Monitor patients for Gentamicin effectiveness.
Succinyl Choline
Adverse Effect: enhanced neuromuscular blockade
Clinical Management: Titrate the dose of Succinyl Choline carefully. Monitor patients not on a ventilator for respiratory paralysis.
Vancomycin
Adverse Effect: nephrotoxicity
Clinical Management: Renal function tests should be closely monitored.
Vecuronium
Adverse Effect: enhanced and/or prolonged neuromuscular blockade which may lead to respiratory depression and paralysis
Clinical Management: Avoid concomitant use of Gentamicin and Vecuronium if possible. Concurrent use of Gentamicin and Vecuronium requires close monitoring of the patients clinical condition, especially respiratory and oxygenation status.

Gabapentin

Ganciclovir(DHPG)

GentamicinSulfate

Glucagon

GriseofulvinMicrosize

Guaifenesin

Gammabenzene Hexachloride